RxDoctor Payments DataLook up a doctor →

Tracie Thornton

Nurse Practitioner · Gadsden, ALNPI 1467962472

Payments from drug & device makers

$9,696in general payments, 2019–2025

Across 490 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Johnson & Johnson$756
  • Incyte Corporation$649
  • E.r. Squibb & Sons, L.L.C.$633
  • Novartis$612
  • Pfizer$591
  • plus $5K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)54$1,061
Johnson & Johnson39$756
Incyte Corporation26$649
E.r. Squibb & Sons, L.L.C.44$633
Novartis38$612
Pfizer43$591
Merck19$458
Seagen Inc.19$441
Bristol Myers Squibb5$290
Astellas Pharma US Inc10$281
Amgen15$229
Array Biopharma Inc13$221
Pharmaessentia USA Corporation8$215
Lilly USA, LLC11$210
Takeda Pharmaceuticals U.S.A., Inc.7$182
Eisai Inc.10$181
Gilead(2 entities)9$164
Sobi, Inc5$162
GSK8$158
Pharmacyclics LLC, An Abbvie Company6$154
Stemline Therapeutics Inc.7$152
Daiichi Sankyo Inc.7$139
Beone Medicines USA, Inc.7$129
Regeneron Healthcare Solutions, Inc.7$128
Beigene USA, Inc.6$103
AbbVie5$100
Jazz Pharmaceuticals Inc.5$94
Rigel Pharmaceuticals, Inc.5$88
Pharmacosmos Therapeutics Inc.4$86
Ipsen Biopharmaceuticals, Inc3$82
Progenics Pharmaceuticals, Inc.4$80
EMD Serono, Inc.3$73
Sumitomo Pharma America, Inc.3$61
Boehringer Ingelheim2$57
Servier Pharmaceuticals LLC3$49
Blueprint Medicines Corporation2$48
Sanofi2$46
Mirati Therapeutics, Inc.2$44
Immunocore Limited1$44
Genentech USA, Inc.2$42
Recordati_rare_diseases_inc.2$37
Karyopharm Therapeutics Inc.2$35
Dendreon Pharmaceuticals LLC1$32
Puma Biotechnology, Inc.2$32
Exelixis Inc.1$29
GE HealthCare1$25
AMAG Pharmaceuticals, Inc.1$22
Deciphera Pharmaceuticals Inc.1$21
Agios Pharmaceuticals, Inc.1$21
Fennec Pharmaceuticals, Inc.1$21
Kyowa Kirin, Inc.1$20
Taiho Oncology, Inc.1$19
AVEO Pharmaceuticals, Inc.1$19
Global Blood Therapeutics, Inc.1$17
Myriad Genetic Laboratories, Inc.1$17
Coherus Oncology, Inc.1$14
Spectrum Pharmaceuticals Inc.1$14
Acceleron Pharma, Inc.1$12

How this compares

$9,696 in reported general payments places this provider in the 95th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama →

Medicare billing

Part B allowed, 2024
$231,953
Medicare patients
170
Services billed
29,794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Gadsden

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →